I joined Health Advances in 2005 and lead the firm’s Diagnostics and Life Science Tools Practice, a global practice which combines consulting and scientific experience to provide results oriented commercialization strategies for our clients. Our practice's work includes application and R&D prioritization, launch strategy, corporate strategy and portfolio optimization, deal diligence, international and domestic market analysis using both qualitative and quantitative approaches, and pricing and reimbursement strategies. Our clients offer products and services in personalized medicine, point-of-care, mainstream clinical diagnostics, and life science tools and range from small diagnostics and tools start-ups to the largest public companies and non-profit institutions in the industry.